# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Citigroup analyst Nicholas Joseph upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Neutral to Buy and raises the price tar...
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price targe...
Good news for US homebuyers as mortgage rates drop to lowest level since May 2023. Despite this, mortgage applications dip as b...
Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate o...
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raises the price targe...
Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector Perform and raises the price...
2024 GUIDANCESabra is reiterating 2024 earnings guidance ranges as follows (attributable to common stockholders, per diluted co...